Assessment of the influence of an enzymal preparation – a complex of glucoamylase and xylanase from Aspergillus awamori Xyl T-15 on the intestinal microbiom and immunological indicators of rats

Abstract

The requirements for the safety of food products obtained by microbial synthesis are including as obligation for to conduct toxicological studies – the study of various biochemical and immunological markers of toxic effects. The necessity of these studies is explained by a possible change in the structure of food ingredients produced by a microbial cell and, consequently, a change in their biological properties, as well as the possible presence of living forms and/or DNA of producer strains or of their toxic metabolites in these ingredients. At the same time, it is well known that the nutrient composition of foods has a significant impact on the composition and properties of microorganisms that make up the gut microbiome, which, in turn, determines the immune status.

The purpose of the research was to justify the analyses of gut microbiocenosis composition for inclusion in the protocol of safety investigation of foods obtained by microbial synthesis [on the example of an enzyme preparation (EP) – a complex of glucoamylase and xylanase from a genetically modified strain of Aspergillus awamori Xyl T-15].

Material and methods. In experimental studies carried out for 80 days, Wistar rats (males and females) were used. The study of the effect of EP (a complex of glucoamylase and xylanase from a genetically modified Aspergillus awamori Xyl T-15 strain) in dozes 10, 100 and 1000 mg/kg body mass on the cecum microbiome and the immune status (content of cytokines and chemokines: IL-1a, IL-4, IL-6, IL-10, IL-17A, INF-γ, TNF-α, MCP-1, MIP-1a and Regulated on Activation Normal T-cell Expressed and Secreted – RANTES) was carried out.

Results. It has been shown that EP – a complex of glucoamylase and xylanase from A. awamori Xyl T-15 at doses of 100 mg/kg or more causes mild disturbances in the composition of gut microbiocenosis. At the same time, these disorders have a significant immunomodulatory and immunotoxic effect on the body, which manifests itself in a dose-dependent change in the profile of pro-inflammatory cytokines and chemokines in blood and spleen. The adverse effect of EP on the body is probably due to the formation of metabolites that are not formed during usual digestive processes in the gastrointestinal tract. The minimum effective dose (LOAEL) of EP was 100 mg/kg body weight In accordance with established requirements, the activity of the EP should not appear in ready-to-use food. Subject to this requirement, amount of EP entering the body cannot exceed the established LOAEL level. Therefore, a complex of glucoamylase and xylanase can be used in food industry, subject to the establishment of regulations «for technological purposes» for A. awamori Xyl T-15 strain.

Conclusion. The data obtained on the relationship between the state of the microbiome and the immune status upon the introduction of EP indicate the need to include indicators of the state of gut microbiocenosis in the test protocol of safety.

Keywords:genetically modified microorganisms; enzyme preparation; production of microbial synthesis; gut microbiome; immune status

Funding. The work was carried out at the expense of a subsidy for the fulfillment of a state task within the framework of the Program for Fundamental Scientific Research (theme of the Ministry of Education and Science of Russia No. 0529-2019-0057).

Conflict of interest. The authors declare no conflict of interest.

Contribution. The concept and design of the study – Bagryantseva O.V., Khotimchenko S.A.; setting up the experiment, collecting and processing the material – Gmoshinski I.V., Bagryantseva O.V., Shipelin V.A., Sheveleva S.A., Riger N.A., Shumakova A.A., Efimochkina N.R., Markova Yu.M., Tsurikova N.V., Smotrina Yu.V., Sokolov I.E., Kolobanov A.I.; statistical data processing – Gmoshinski I.V.; writing the text, editing, approval of the final version of the article, responsibility for the integrity of all parts of the article – Bagryantseva O.V., Gmoshinski I.V., Khotimchenko S.A.

Acknowledgments. We express our gratitude to the employees of VNIIPBT – filial of the Federal Research Centre of Nutrition, Biotechnology and Food Safety Kostyleva E.V., Sereda A.S., Velikoretskaya I.A., Ignatova N.I. for providing an experimental batch of the enzyme used in the research.

For citation: Bagryantseva O.V., Gmoshinski I.V., Shipelin V.A., Sheveleva S.A., Riger N.A., Shumakova A.A., Efimochkina N.R., Markova Yu.M., Tsurikova N.V., Smotrina Yu.V., Sokolov I.E., Kolobanov A.I., Khotimchenko S.A. Assessment of the influence of an enzymal preparation – a complex of glucoamylase and xylanase from Aspergillus awamori Xyl T-15 on the intestinal microbiom and immunological indicators of rats. Voprosy pitaniia [Problems of Nutrition]. 2022; 91 (3): 42–52. DOI: https://doi.org/10.33029/0042-8833-2022-91-3-42-52 (in Russian)

References

1. Microbiological and molecular genetic evaluation of food obtained using genetically modified microorganisms: Guidelines MU 2.3.2.1830-04. Moscow, 2004: 56 p. (in Russian)

2. Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources. EFSA J. 2018; 16 (6): 5294. DOI: https://doi.org/10.2903/j.efsa.2018.5294

3. EFSA Panel on Biological Hazards (BIOHAZ); Koutsoumanis K., Allende A., Alvarez-Ordonez A., Bolton D., Bover-Cid S., Chemaly M., et al. Scientific Opinion on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017–2019). EFSA J. 2020; 18 (2): e05966. DOI: https://doi.org/10.2903/j.efsa.2020.5966

4. Analysis of JECFA’s draft guideline on «Evaluation of enzyme preparations used in the manufacture of foods». EFSA Supporting Publication, 2020: 8 p. DOI: https://doi.org/10.2903/sp.efsa.2020.EN-1795

5. García-Montero C., Fraile-Martínez O., Gomez-Lahoz A.M., Pekarek L., Castellanos A.J., Noguerales-Fraguas F., et al. Nutritional components in Western diet versus Mediterranean diet at the gut microbiota-immune system interplay. implications for health and disease. Nutrients. 2021; 13 (2): 699. DOI: https://doi.org/10.3390/nu13020699

6. Lazar V., Ditu L.-M., Pircalabioru G.G., Gheorghe I., Curutiu C., et al. Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol. 2018; 9: 1830. DOI: https://doi.org/10.3389/fimmu.2018.01830

7. Chen L.L., Abbaspour A., Mkoma G.F., Bulik C.M., Rück C., Djurfeldt D. Gut microbiota in psychiatric disorders: a systematic review. Psychosom Med. 2021; 83: 679–92. DOI: https://doi.org/10.1097/PSY.0000000000000959

8. Di Guglielmo M.D., Franke K.R., Robbins A., Crowgey E.L. Impact of early feeding: metagenomics analysis of the infant gut microbiome. Front Cell Infect Microbiol. 2022; 12: 816601. DOI: https://doi.org/10.3389/fcimb.2022.816601

9. Chandra P., Enespa, Singh R., Arora P.K. Microbial lipases and their industrial applications: a comprehensive review. Microb Cell Fact. 2020; 19: 169. DOI: https://doi.org/10.1186/s12934-020-01428-8

10. Tavares N.K., Zayas C.L., Escalante-Semerena J.-C. The Methanosarcina mazei MM2060 gene encodes a bifunctional kinase/decarboxylase enzyme involved in cobamide biosynthesis. Biochemistry. 2018; 57 (30): 4478–95. DOI: https://doi.org/10.1021/acs.biochem.8b00546

11. Textbook of biochemistry with clinical correlations. Edited by Devlin T.M. 5th ed. New York: John Wiley & Sons, 2001: 1216 p. ISBN 0-471-41136-1.

12. Bagryantseva O.V., Khotimchenko S.A., Sheveleva S.A., Minaeva L.P., Semenova P.A. On the use of the enzyme transglutaminase in the food industry. Pishchevaya promyshlennost’ [Food Processing Industry]. 2021; (10): 78–81. DOI: https://doi.org/10.52653/PPI.2021.10.10.016 (in Russian)

13. Rimareva L.V., Tsurikova N.V., Kostyleva E.V., Sereda A.S. Recombinant strain of filamentous fungus Aspergillus awamori – producer of a complex of enzymes glucoamylase and xylanase. RU Patent No. 2457246, priority dated 21.03.2011. (in Russian)

14. Rozhkova A.M., Sereda A.S., Tsurikova N.V., Nurtaeva A.K., Semenova P.A., Rimareva L.V., et al. Creation of a system for the expression of heterologous genes based on a recombinant strain of the fungus Aspergillus awamori. Prikladnaya biokhimiya i mikrobiologiya [Applied Biochemistry and Microbiology]. 2011; 47 (3): 308–17. (in Russian)

15. Guide for the care and use of laboratory animals. 8th ed. In: Committee for the Update of the Guide for the Care and Use of Laboratory Animals; Institute for Laboratory Animal Research (ILAR); Division on Earth and Life Studies (DELS); National Research Council of the national academies. Washington: The National Academies Press, 2011.

16. Handbook of microbiological and virological research methods. Edited by M.O. Birger. Moscow: Meditsina, 1982: 464 p. (in Russian)

17. Gause G.F. Key to actinomycetes: Genera Streptomyces, Streptoverticillium, Chainia. Moscow, 2021: 248 p. ISBN 978-5-458-47107-7 (in Russian)

18. Bergey’s Manual of Systematic Bacteriology. 9th ed. Edited by J.G. Holt, H.R. Krieg. Baltimore, London: Williams and Wilkins, 1994: 787 p. ISBN 978-0683006032.

19. Stemke D.J. Genetically modified microorganisms. biosafety and ethical issues. Edited by S.R. Parekh. The GMO Handbook: Genetically Modified Animals, Microbes, and Plants in Biotechnology. Totowa, NJ: Humana Press, 2004: 85–130.

20. Lee G.R. The balance of Th17 versus Treg cells in autoimmunity. Int J Mol Sci. 2018; 19 (3): E730. DOI: https://doi.org/10.3390/ijms19030730.

21. Bagryantseva O.V., Gmoshinski I.V., Shipelin V.A., Tsurikova N.V., Sheveleva S.A., et al. Assessment of health risks of an enzyme preparation - a complex of glucoamylase and xylanase from Aspergillus awamori Xyl T-15. Voprosy pitaniia [Problems of Nutrition]. 2021; 90 (3): 28–39. DOI: https://doi.org/10.33029/0042-8833-2021-90-3-28-39 (in Russian)

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

SCImago Journal & Country Rank
Scopus CiteScore
CHIEF EDITOR
CHIEF EDITOR
Viktor A. Tutelyan
Full Member of the Russian Academy of Sciences, Doctor of Medical Sciences, Professor, Scientific Director of the Federal Research Centre of Nutrition, Biotechnology and Food Safety (Moscow, Russia)

Journals of «GEOTAR-Media»